Aesthetic Medical International Holdings Group Limited (PAIYY) - Total Liabilities
Based on the latest financial reports, Aesthetic Medical International Holdings Group Limited (PAIYY) has total liabilities worth $484.61 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Aesthetic Medical International Holdings (PAIYY) cash flow conversion to assess how effectively this company generates cash.
Aesthetic Medical International Holdings Group Limited - Total Liabilities Trend (2020–2024)
This chart illustrates how Aesthetic Medical International Holdings Group Limited's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Aesthetic Medical International Holdings's assets to evaluate the company's liquid asset resilience ratio.
Aesthetic Medical International Holdings Group Limited Competitors by Total Liabilities
The table below lists competitors of Aesthetic Medical International Holdings Group Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ASA International Group PLC
LSE:ASAI
|
UK | GBX536.07 Million |
|
Cumulus Media Inc Class A
NASDAQ:CMLS
|
USA | $1.11 Billion |
|
Divio Technologies AB Series B
ST:DIVIO-B
|
Sweden | Skr29.57 Million |
|
Great Western Mining Corp Plc
IR:8GW
|
Ireland | €453.84K |
|
Dios Exploration Inc.
V:DOS
|
Canada | CA$131.84K |
|
Twin Vee Powercats Co
NASDAQ:VEEE
|
USA | $2.96 Million |
|
Range International Ltd
AU:RAN
|
Australia | AU$1.01 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Aesthetic Medical International Holdings Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Aesthetic Medical International Holdings (PAIYY) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 20.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aesthetic Medical International Holdings Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aesthetic Medical International Holdings Group Limited (2020–2024)
The table below shows the annual total liabilities of Aesthetic Medical International Holdings Group Limited from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $476.88 Million | -9.52% |
| 2023-12-31 | $527.03 Million | -21.60% |
| 2022-12-31 | $672.25 Million | -11.94% |
| 2021-12-31 | $763.36 Million | +24.66% |
| 2020-12-31 | $612.35 Million | -- |
About Aesthetic Medical International Holdings Group Limited
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency tr… Read more